- £132.53m
- £135.85m
- £0.27m
Annual balance sheet for 4Basebio, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Short Term Investments | 0.08 | 15 | 9.59 | 4.35 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 0.18 | 0.102 | 0.604 | 1.02 |
| Total Inventory | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 0.598 | 15.5 | 10.6 | 5.9 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 0.078 | 1.48 | 2.76 | 3.63 |
| Net Intangible Assets | ||||
| Other Long Term Assets | ||||
| Total Assets | 1.16 | 17.8 | 14.7 | 11.7 |
| Accounts Payable | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.566 | 0.813 | 1.52 | 1.52 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 3.04 | 2.35 | 3.01 | 4.57 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | -1.89 | 15.5 | 11.7 | 7.12 |
| Total Liabilities & Shareholders' Equity | 1.16 | 17.8 | 14.7 | 11.7 |
| Total Common Shares Outstanding |